MDxHealth Lowers FY2026 Sales Guidance from $137.000M-$140.000M to $110.000M-$115.000M vs $135.912M Est

Benzinga Newsdesk www.benzinga.com Negative 96.2%

Neg 96.2% Neu 0% Pos 0%

MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.000 million-$115.000 million vs $135.912 million estimate.